DOSSIER · 13F Holders · Q4 2025Most-boughtAI cap-ex
LCTX
LINEAGE CELL THERAPEUTIC
138 institutions still hold LINEAGE CELL THERAPEUTIC as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 53566p109·138 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
138 institutions reported LCTX in Q4 2025. BROADWOOD CAPITAL INC leads at 47.3% of the visible book. -58 net institutions QoQ — distribution reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 7
118 more holders available. Log in →